|
|
 | | | |
- close
- close
- close
- close
Diagnostic Substances |
Benzinga
Apr 18
Comment
Below are the top small-cap diagnostic substances stocks on the NYSE and the NASDAQ in terms of operating margin.
The trailing-twelve-month operating margin at SurModics (NASDAQ: SRDX) is 33.41%. SurModics' ROE for the same period is...
Benzinga
Mar 20
Comment
Below are the top diagnostic substances stocks on the NASDAQ in terms of revenue.
The trailing-twelve-month revenue at IDEXX Laboratories (NASDAQ: IDXX) is $1.29 billion. IDEXX had $223.99 million in total cash for the latest quarter.
The...
Benzinga
Feb 21
Comment
Below are the top small-cap diagnostic substances stocks on the NYSE and the NASDAQ in terms of earnings estimate for the next quarter.
Abaxis (NASDAQ: ABAX) is estimated to post earnings of $0.24 per share in the June quarter. Abaxis'...
Benzinga
Jan 24
Comment
Below are the top diagnostic substances stocks on the NASDAQ in terms of revenue estimate for the current year.
Analysts expect IDEXX Laboratories (NASDAQ: IDXX) to post revenue of $1.30 billion for the year ending December, 2012. IDEXX had...
Benzinga
Jan 8
Comment
Below are the top diagnostic substances stocks on the NASDAQ in terms of profit margin.
The trailing-twelve-month profit margin at Trinity Biotech plc (NASDAQ: TRIB) is 20.71%. Trinity Biotech's revenue for the same period is $81.70...
Benzinga
Dec 20
Comment
Below are the top diagnostic substances stocks on the NYSE and the NASDAQ in terms of profit margin.
The trailing-twelve-month profit margin at Trinity Biotech plc (NASDAQ: TRIB) is 20.71%. Trinity Biotech's ROA for the same period is...
Benzinga
Oct 24
Comment
Below are the top small-cap diagnostic substances stocks on the NYSE and the NASDAQ in terms of return on equity.
The trailing-twelve-month return on equity at Meridian Bioscience (NASDAQ: VIVO) is 22.58%. Meridian Bioscience's revenue for the...
Benzinga
Oct 10
Comment
Below are the top small-cap diagnostic substances stocks on the NYSE and the NASDAQ in terms of earnings estimate for the next year.
Neogen (NASDAQ: NEOG) is likely to earn $1.30 per share in the next year ending May, 2014. Neogen's PEG ratio...
Benzinga
Sep 21
Comment
Below are the top diagnostic substances stocks on the NASDAQ in terms of profit margin.
The trailing-twelve-month profit margin at Trinity Biotech plc (NASDAQ: TRIB) is 20.32%. Trinity Biotech's ROE for the same period is 10.69%.
The...
Benzinga
Aug 2
Comment
Below are the top diagnostic substances stocks on the NASDAQ in terms of cash.
AMAG Pharmaceuticals (NASDAQ: AMAG) had $207.25 million in total cash for the latest quarter. However, AMAG Pharmaceuticals had no debt for the same period.
IDEXX...
Suggest other news sources for this topic
more ▼WIKI ANALYSIS
WIKI ANALYSISCompanies in the Diagnostic Substances Industry (36)
|
| |||||||
